PHARMA
EXECUTIVE ADVISORY BOARD

The Executive Advisory Board is ideally placed to provide expert insight into the critical issues and challenges facing the pharma industry today. Together they bring a wealth of first-hand experience and knowledge, sharing our determination to encourage further collaboration amongst key stakeholders shaping the future of the pharma industry.

We have assembled a group of recognised experts and practitioners from big and emerging pharma, the generics industry and the wider outsourcing community. The committee will convene several times a year to influence the programme of Pharma Integrates, ensuring it reflects key industry concerns and advising on current industry developments and potential speakers. Kindly contact Christopher Watt or Samuel Thangiah if you would like to be considered for the Pharma Executive Advisory Board.

PROF TREVOR JONES CBE
Director

Arix Bioscience & e-Therapeutics

Jo Pisani

JO PISANI
Partner, UK Pharma and Life Sciences Consulting Lead

Strategy&, part of the PwC network

Mark Cassidy

MARK CASSIDY
Head of Strategy and Commercial Operations

Ajinomoto Bio-Pharma Services

Cornell Stamoran

CORNELL STAMORAN
Vice President, Strategy and Corporate Development

Catalent Pharma Solutions

BRIAN HENRY
Vice President, Global Head of Drug Product Design

Pfizer Worldwide Research and Development

Ian Muir

IAN MUIR
Chief Executive Officer

FAMAR

MARCO MOHWINCKEL
Chief Commercial Officer

COMPASS Pathways

CLIVE BADMAN
Executive Director and PTS Pre-Competitive Activities and Project Director

University of Strathclyde & ReMediES

Alex Robertson

ALEX ROBERTSON
Senior Director, Supply Chain Management, Pharmaceutical Development

Astrazeneca

GINO MARTINI
Chief Scientist & Director

Royal Pharmaceutical Society & Bioepic

Tina Flatau

TINA FLATAU
Managing Director

MedAnnex

MARTIN LUSH
Global Vice President, Pharma Biotech and Medical Devices

NSF Health Sciences

JONATHAN BLAMEY
Vice President, Global Product & Account Leader, Global Life Sciences & Healthcare Team

DHL Supply Chain

NICHOLAS JOHNSON
Commercial Director

Centre for Process Innovation

JACQUELINE KARMEL
Principal International Scientific Director, Global Medical Team Lead, Cancer Immunotherapy

Roche

Loy

LOY LOBO
President Elect, Digital Health Council, Royal Society of Medicine

Visiting Lecturer, Imperial College Business School

Georg Bucgner

GEORG BUCHNER
Head of Licensing & Business Development (Commercial Operations)

Helsinn Healthcare

Massimo

MASSIMO BRESCIANI
Executive Director Scientific Operations & Board Member

Research Centre for Pharmaceutical Engineering & Geriatric Medicines Society

MARK DUMAN
Managing Director & Assessor- Digital Health; BioMedical Catalyst

MD Healthcare Consultants & Innovate UK Medicines Society

STEVE BARR
Vice President Business Development

SK biotek

TONY SEDGWICK
Life Science Advisor, Strategy, Products & People

The Thought Disruptor

JESUS ZURDO
Senior Vice President Procurement Science & Innovation

Rentschler Biopharma

STUART NEEDLEMAN
Chief Commercial Officer

Piramal Pharma Solutions

CHRISTIAN JONES
Chief Commercial Officer

Nanoform

MARC GOEMANS
Commercial Director

Consort Medical

NICK SHACKLEY
President of Innovator Products and Solutions

Johnson Matthey

Andrew

ANDREW FRIED
Life Sciences – Global Industry Leader

IBM